Ultrasound and FibroScan® Controlled Attenuation Parameter in patients with MAFLD: head to head comparison in assessing liver steatosis

European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO), EASL-EASD-EASO Clinical Practice Guidelines for the management of nonalcoholic fatty liver disease. J. Hepatol. 64(6), 1388–1402 (2016). https://doi.org/10.1016/j.jhep.2015.11.004

D.E. Kleiner, E.M. Brunt, M. Van Natta et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6), 1313–1321 (2005). https://doi.org/10.1002/hep.20701

Article  PubMed  Google Scholar 

A. Lonardo, F. Nascimbeni, A. Mantovani, G. Targher, Hypertension, diabetes, atherosclerosis and NASH: cause or consequence. J. Hepatol. 68(2), 335–352 (2018). https://doi.org/10.1016/j.jhep.2017.09.021

Article  PubMed  Google Scholar 

S. Bellentani, F. Scaglioni, M. Marino, G. Bedogni, Epidemiology of non-alcoholic fatty liver disease. Dig. Dis. 28(1), 155–161 (2010). https://doi.org/10.1159/000282080

Article  CAS  PubMed  Google Scholar 

N. Chalasani, Z. Younossi, J.E. Lavine et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67(1), 328–357 (2018). https://doi.org/10.1002/hep.29367

Article  PubMed  Google Scholar 

J. Ma, S.J. Hwang, A. Pedley et al. Bi-directional analysis between fatty liver and cardiovascular disease risk factors. J. Hepatol. 66(2), 390–397 (2017). https://doi.org/10.1016/j.jhep.2016.09.022

Article  PubMed  Google Scholar 

F. Bril, K. Cusi, Management of nonalcoholic fatty liver disease in patients with type 2 diabetes: a call to action. Diabetes Care 40(3), 419–430 (2017). https://doi.org/10.2337/dc16-1787

Article  PubMed  Google Scholar 

K. Lau, R. Lorbeer, R. Haring et al. The association between fatty liver disease and blood pressure in a population-based prospective longitudinal study. J. Hypertens. 28(9), 1829–1835 (2010). https://doi.org/10.1097/HJH.0b013e32833c211b

Article  CAS  PubMed  Google Scholar 

N. Assy, K. Kaita, D. Mymin, C. Levy, B. Rosser, G. Minuk, Fatty infiltration of liver in hyperlipidemic patients. Dig. Dis. Sci. 45(10), 1929–1934 (2000). https://doi.org/10.1023/a:1005661516165

Article  CAS  PubMed  Google Scholar 

M. Eslam, P.N. Newsome, S.K. Sarin et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J. Hepatol. 73(1), 202–209 (2020). https://doi.org/10.1016/j.jhep.2020.03.039

Article  PubMed  Google Scholar 

F. Bril, C. Ortiz-Lopez, R. Lomonaco et al. Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients. Liver Int. 35(9), 2139–2146 (2015). https://doi.org/10.1111/liv.12840

Article  CAS  PubMed  Google Scholar 

V. de Lédinghen, J. Vergniol, J. Foucher, W. Merrouche, B. le Bail, Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int. 32(6), 911–918 (2012). https://doi.org/10.1111/j.1478-3231.2012.02820.x

Article  PubMed  Google Scholar 

European Association for the Study of the Liver, Electronic address: easloffice@easloffice.eu; Clinical Practice Guideline Panel; Chair:; EASL Governing Board representative:; Panel members:. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J. Hepatol. 75(3), 659–689 (2021). https://doi.org/10.1016/j.jhep.2021.05.025

Article  Google Scholar 

S.M. Grundy, J.I. Cleeman, S.R. Daniels, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [published correction appears in Circulation. 2005 Oct 25;112(17):e297] [published correction appears in Circulation. 2005 Oct 25;112(17):e298]. Circulation 112(17), 2735–2752 (2005). https://doi.org/10.1161/CIRCULATIONAHA.105.169404

Article  PubMed  Google Scholar 

M. Hamaguchi, T. Kojima, Y. Itoh et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am. J. Gastroenterol. 102(12), 2708–2715 (2007). https://doi.org/10.1111/j.1572-0241.2007.01526.x

Article  PubMed  Google Scholar 

Q. Li, M. Dhyani, J.R. Grajo, C. Sirlin, A.E. Samir, Current status of imaging in nonalcoholic fatty liver disease. World J. Hepatol. 10(8), 530–542 (2018). https://doi.org/10.4254/wjh.v10.i8.530

Article  PubMed  PubMed Central  Google Scholar 

T. Karlas, D. Petroff, M. Sasso et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J. Hepatol. 66(5), 1022–1030 (2017). https://doi.org/10.1016/j.jhep.2016.12.022

Article  PubMed  Google Scholar 

P.J. Eddowes, M. Sasso, M. Allison et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 156(6), 1717–1730 (2019). https://doi.org/10.1053/j.gastro.2019.01.042

Article  PubMed  Google Scholar 

R. Hernaez, M. Lazo, S. Bonekamp et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54(3), 1082–1090 (2011). https://doi.org/10.1002/hep.24452

Article  PubMed  Google Scholar 

Y.N. Zhang, K.J. Fowler, G. Hamilton et al. Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging. Br. J. Radio. 91(1089), 20170959 (2018). https://doi.org/10.1259/bjr.20170959

Article  Google Scholar 

G. Ferraioli, A. Berzigotti, R.G. Barr et al. Quantification of liver fat content with ultrasound: a WFUMB position paper. Ultrasound Med Biol. 47(10), 2803–2820 (2021). https://doi.org/10.1016/j.ultrasmedbio.2021.06.002

Article  PubMed  Google Scholar 

K. Cusi, S. Isaacs, D. Barb et al. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocr. Pr. 28(5), 528–562 (2022). https://doi.org/10.1016/j.eprac.2022.03.010

Article  Google Scholar 

B.R. Chen, C.Q. Pan, Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease. Clin. Res Hepatol. Gastroenterol. 46(1), 101755 (2022). https://doi.org/10.1016/j.clinre.2021.101755

Article  CAS  PubMed  Google Scholar 

G. Ferraioli, A. Berzigotti, R.G. Barr et al. Quantification of liver fat content with ultrasound: a WFUMB position paper. Ultrasound Med Biol. 47(10), 2803–2820 (2021). https://doi.org/10.1016/j.ultrasmedbio.2021.06.002

Article  PubMed  Google Scholar 

M.S. Siddiqui, R. Vuppalanchi, M.L. Van Natta et al. Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 17(1), 156–163.e2 (2019). https://doi.org/10.1016/j.cgh.2018.04.043

Article  PubMed  Google Scholar 

S.B. Ahn, D.W. Jun, B.K. Kang, M. Kim, M. Chang, E. Nam, Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting. Med. (Baltim.) 97(50), e13636 (2018). https://doi.org/10.1097/MD.0000000000013636

Article  Google Scholar 

V.W. Wong, S. Petta, J.B. Hiriart et al. Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter. J. Hepatol. 67(3), 577–584 (2017). https://doi.org/10.1016/j.jhep.2017.05.005

Article  PubMed  Google Scholar 

V. Rosato, A. Ascione, R. Nevola et al. Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicentre prospective study. J. Viral Hepat. 29(1), 26–34 (2022). https://doi.org/10.1111/jvh.13617

Article  CAS  PubMed  Google Scholar 

A. Salmi, One-minute liver “digitopsy” for point of care risk stratification of fibrosis in nonalcoholic fatty liver disease. Minerva Gastroenterol. (Torino) 67(2), 209–210 (2021). https://doi.org/10.23736/S2724-5985.20.02700-2

Article  Google Scholar 

A. Salmi, G. Lanzani, P. Campagnola, L. Frulloni,, Teaching echoscopy for the early diagnosis of ascites in cirrhosis: assessment of an objective structured clinical examination (OSCE). J. Ultrasound 20(2), 123–126 (2017). https://doi.org/10.1007/s40477-017-0250-9

Article  Google Scholar 

留言 (0)

沒有登入
gif